0.00
—
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Lotus Pharmaceuticals
Its shares trade under the ticker LTUS. It has been listed since 15 May 2012.
Lotus Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products in the People's Republic of China. The company is headquartered in Beijing, Beijing. The company went IPO on 2012-05-15. The firm produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. Its drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The company operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. (Liang Fang) and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd. (En Zhe Jia), collectively Lotus East. Lotus East is engaged in the production, trade and retailing of pharmaceuticals, focusing on the development of medicines and investing in strategic growth to address various medical needs. Lotus East owns and operates 10 drug stores throughout Beijing, China that sell Western and traditional Chinese medications, and generate revenues from the leasing of retail space to third party vendors in its retail stores.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 15 May 2012
- Employees
- 233
- Website
- lotuspharma.com ↗
Leadership
Pay as last reported
- Dr. Zhongyi LiuChairman of the Board, President, Chief Executive Officer, since 2006$180,000
- Mr. Yan ZengChief Financial Officer
- Dr. Xing ShenVice President - Corporate Development
- Lu JunDirector
- Fan LijunIndependent Director
- Li ZhaohuiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Lotus Pharmaceuticals Inc has several strengths that contribute to its competitive advantage and market position. Firstly, the company has a strong research and development (R&D) team, enabling it to innovate and develop new pharmaceutical products. This gives Lotus Pharmaceuticals an edge in terms of introducing novel treatments to the market. Additionally, the company has a diverse product portfolio, covering various therapeutic areas, which helps in reducing reliance on a single product or market segment. Furthermore, Lotus Pharmaceuticals prides itself on maintaining high quality standards and complying with stringent regulatory guidelines, ensuring its products are safe and effective.
Weaknesses
- Despite its strengths, Lotus Pharmaceuticals Inc also faces certain weaknesses that can impact its growth and competitiveness. One key weakness is its limited global reach and market penetration. The company primarily operates within a specific geographical region, which restricts its access to a broader customer base and potential market opportunities. Another weakness is the lack of strong brand recognition, especially when compared to larger pharmaceutical companies. This can pose challenges in customer acquisition and brand loyalty.
Opportunities
- Lotus Pharmaceuticals Inc has several opportunities that it can capitalize on to drive growth and expand its market presence. The increasing demand for affordable and effective healthcare in emerging markets presents a significant opportunity for the company to expand its operations into these regions. By strategically targeting these markets, Lotus Pharmaceuticals can tap into a large customer base and gain a competitive edge. Additionally, with the advancements in technology and digital healthcare, the company can explore innovative solutions such as telemedicine and digital therapeutics to enhance its product offerings and reach a wider range of customers.
Threats
- Lotus Pharmaceuticals Inc faces certain threats that pose challenges to its business and profitability. One major threat is intense competition within the pharmaceutical industry, both from established companies and emerging players. This can lead to price wars, reduced profit margins, and higher marketing expenses. Furthermore, the company is susceptible to regulatory changes and compliance requirements, which may increase operational costs and impact product development timelines. Additionally, economic downturns and fluctuations in currency exchange rates can negatively affect Lotus Pharmaceuticals' financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.